Angelini Industries
Angelini Industries, headquartered in Italy, is a prominent player in the pharmaceutical and consumer goods sectors. Founded in 1919, the company has established a strong presence across Europe, Latin America, and Asia, focusing on health and well-being. With a diverse portfolio that includes prescription medicines, over-the-counter products, and personal care items, Angelini Industries is renowned for its commitment to quality and innovation. The company’s unique approach combines scientific research with a deep understanding of consumer needs, setting it apart in a competitive market. Notable achievements include a robust market position in various therapeutic areas, particularly in pain management and mental health. Angelini Industries continues to drive growth through strategic partnerships and a dedication to sustainable practices, reinforcing its reputation as a leader in the industry.
DitchCarbon Score
How does Angelini Industries's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Angelini Industries's score of 37 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Angelini Industries's reported carbon emissions
In 2023, Angelini Industries reported total carbon emissions of approximately 18,618,900 kg CO2e for Scope 1 and about 11,363,270 kg CO2e for Scope 2 emissions. This marks a reduction from 2022, where emissions were approximately 16,914,700 kg CO2e for Scope 1 and about 15,556,900 kg CO2e for Scope 2. The company has achieved a significant reduction target, successfully decreasing its greenhouse gas (GHG) emissions by 3% compared to the previous fiscal year, despite an increase in production. Angelini Industries has set ambitious climate commitments, aiming for a net-zero target by 2040 across all scopes. Specific near-term goals include a 4% reduction in CO2 emissions per metric ton of MSU produced for Scope 2 and a commitment to reduce GHG emissions in line with the Paris Agreement, with a baseline carbon footprint to be finalised in 2024. Additionally, the company has previously reduced emissions at production sites by more than 1,000 tonnes per year from a baseline of 16,845.608 tonnes of CO2 emitted in 2020. Overall, Angelini Industries is actively working towards reducing its carbon footprint and enhancing its sustainability practices, demonstrating a commitment to environmental responsibility in the pharmaceutical and consumer goods sectors.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 24,486,720 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 29,856,680 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Angelini Industries is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
